JSW
ZYME icon

Journey Strategic Wealth’s Zymeworks ZYME Stock Holding History

Journey Strategic Wealth’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$727K Hold
29,050
– – 0.02% 251
2025
Q4 		$765K Hold
29,050
– – 0.02% 222
2025
Q3 		$496K Buy
29,050
+10
+0% +$143 0.01% 298
2025
Q2 		$364K Buy
29,040
+99
+0.3% +$1.18K 0.01% 373
2025
Q1 		$345K Buy
28,941
+44
+0.2% +$600 0.01% 301
2024
Q4 		$423K Hold
28,897
– – 0.02% 253
2024
Q3 		$363K Hold
28,897
– – 0.01% 286
2024
Q2 		$246K Buy
28,897
+51
+0.2% +$454 0.01% 304
2024
Q1 		$303K Hold
28,846
– – 0.01% 185
2023
Q4 		$300K Hold
28,846
– – 0.01% 137
2023
Q3 		$183K Hold
28,846
– – 0.01% 178
2023
Q2 		$249K Hold
28,846
– – 0.01% 144
2023
Q1 		$261K Hold
28,846
– – 0.03% 181
2022
Q4 		$227K Hold
28,846
– – 0.03% 186
2022
Q3 		$177K Hold
28,846
– – 0.02% 163
2022
Q2 		$153K Hold
28,846
– – 0.02% 112
2022
Q1 		$189K Hold
28,846
– – 0.02% 166
2021
Q4 		$473K Buy
+28,846
New +$601K 0.05% 74

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Journey Strategic Wealth's ZYME Position: Q1 2026 in Review

Journey Strategic Wealth held its Zymeworks (ZYME) position steady in Q1 2026 at 29,050 shares worth $727K. The position accounts for 0.02% of the portfolio, ranked #251.

Journey Strategic Wealth first reported a position in ZYME in Q4 2021 and has held it in 18 quarters since. The position peaked at $765K in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Journey Strategic Wealth held 29,050 shares of Zymeworks worth $727K as of Q1 2026.
  • Journey Strategic Wealth left its Zymeworks share count unchanged in Q1 2026.
  • Zymeworks made up 0.02% of Journey Strategic Wealth's portfolio in Q1 2026, its #251 holding.
  • Journey Strategic Wealth first reported a position in Zymeworks in Q4 2021 and has held it in 18 quarters since.
  • Journey Strategic Wealth's Zymeworks position peaked at $765K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.